Literature DB >> 11027140

Structure of lithocholic acid binding to the N-terminal 8-kDa domain of DNA polymerase beta.

Y Mizushina1, T Ohkubo, F Sugawara, K Sakaguchi.   

Abstract

The purpose of this study was to investigate the molecular action of lithocholic acid (LCA), known as a selective inhibitor of DNA polymerase beta (pol beta). The 39-kDa pol beta was separated proteolytically into two fragments of the template-primer binding domain (8 kDa) and the catalytic domain (31 kDa). LCA bound tightly to the 8-kDa fragment but not to the 31-kDa fragment. We examined the structural interaction with the 8-kDa domain using LCA. On (1)H-(15)N HMQC NMR analysis of pol beta with LCA, the 8-kDa domain bound to LCA as a 1:1 complex with a dissociation constant (K(D)) of 1.56 mM. The chemical shifts were observed only in residues mainly in helix-3, helix-4, and the 79-87 turn of the same face. No significant shifts were observed for helix-1, helix-2, and other loops of the 8-kDa domain. This region was composed mainly of three amino acid residues (Lys60, Leu77, and Thr79) of pol beta on the LCA interaction interface. The inhibition mechanism and the structure-function relationship between pol beta and LCA is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027140     DOI: 10.1021/bi001276m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.

Authors:  Gregory C Stachelek; Shibani Dalal; Katherine A Donigan; Denise Campisi Hegan; Joann B Sweasy; Peter M Glazer
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

2.  The relationship between the molecular structure of natural acetogenins and their inhibitory activities which affect DNA polymerase, DNA topoisomerase and human cancer cell growth.

Authors:  Yuki Matsui; Toshifumi Takeuchi; Yuko Kumamoto-Yonezawa; Masaharu Takemura; Fumio Sugawara; Hiromi Yoshida; Yoshiyuki Mizushina
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

3.  3-O-methylfunicone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain.

Authors:  Yoshiyuki Mizushina; Hirohisa Motoshima; Yasuhiro Yamaguchi; Toshifumi Takeuchi; Ken Hirano; Fumio Sugawara; Hiromi Yoshida
Journal:  Mar Drugs       Date:  2009-11-23       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.